Further, GSDMD inhibitors have been described (Hu et al, 2020; Humphries et al, 2020), of which dimethyl fumarate is already being used in the treatment of multiple sclerosis (Humphries et al, 2020). Here, GSDMD is linked to multiple sclerosis.